If we know that cancer A ends deadly in an an average of 6 months for 90% of the population and if our treatment has wildly different results, why wonder?
If we know that cancer A ends deadly in an an average of 6 months for 90% of the population and if our treatment has wildly different results, why wonder?
If a patient thinks they are on a treatment, they might actually end up healthier than a patient who has just been told there are no treatment options left for them...
Likewise, if a clinician is really hoping the new drug they are developing is successful, their judgement of exactly how quickly a tumour is growing might not be fully impartial.
However, there is no need for the control group and treatment group to be 50/50. The control group can also be shared with other studies - although that makes risk budget allocation complex, but not impossible.
Isn't the actual aim? to have someone heal?
> Likewise, if a clinician is really hoping the new drug they are developing is successful, their judgement of exactly how quickly a tumour is growing might not be fully impartial
Well, this is something that is quantifiable I guess (a measurement). And changes must be notable in order to call something a success in that case.
https://www.cancer.net/research-and-advocacy/clinical-trials...
- Trials tend to be conducted at the best facilities, and they monitor their patients extremely well. Thus, control groups in a trial tend to have a better outcome than the general population.
- Patients included in trials tend to be better informed and better motivated to seek treatment.
- When trials are run in a specific location, the patient group may be different than the general population (younger/older, less/more exposure to carcinogens, etc.).
Note that all of these are in favor of approval for the experimental drug, and combined with financial interest/pressure from pharmaceutical companies to get approval of a drug, leaving out a control group is a recipe for disaster.
The hypothetical case you describe where a cancer ends deadly in an average of 6 months for 90% of the population and is suddenly cured by a miracle treatment simply does not happen (see https://www.cancerresearchuk.org/health-professional/cancer-... for some statistics), so you will always need a control group.
That was an exaggeration (in line with the title of the article) - what I meant are cases where we historically have a good knowledge of the trajectory of an illness and this could be used as the control group.